Abstract:Objective To investigate the clinical features,diagnosis and treatment of Gynura segetum-related hepatic sinusoidal obstruction syndrome (HSOS).Methods From January 2010 to May 2017,458 hospitalized patients with HSOS from 29 hospitals were enrolled,and among them 239 cases were Gynura segetum-related HSOS.The diagnostic value of clinical signs in Gynura segetum-related HSOS were evaluated by Seattle criteria which used in HSOS caused by hemopoietic stem cells transplantation.The pathological diagnosis of liver biopsy was taken as gold standard.The diagnostic value of computed tomography (CT)/magnetic resonance imaging (MRI) in Gynura segetum-related HSOS was also investigated.Sensitivity,specificity,positive predictive value,negative predictive value,accuracy and Kappa value were used for the assessment of diagnostic value.Cox regression analysis was performed for prognosis analysis.Results Among 362 patients with drugs related HSOS,239 cases (66.02％) was Gynura segetum-related HSOS and 232 (97.07％) of the 239 patients with Gynura segetum-related HSOS presented with ascites.The diagnostic sensitivity and specificity of ascites in HSOS were 97.07％ and 75.86％,respectively,and the Kappa value was 0.751.The diagnostic sensitivities of patchy map-like enhancement and (or) heterogeneous hypoattenuation of CT or inhomogeneous signal of MRI were 100.0％ and 97.4％,respectively;and the specificities were 88.9％ and 100.0％,respectively,and both of the Kappa value were more than 0.75,with excellent consistency.The accuracies of patchy enhancement,heterogeneous hypoattenuation of CT or inhomogeneous signal of MRI and ascites were all over 90 ％.Among 239 patients with Gynura segetum-related HSOS,229 (95.82 ％) patients were treated with hepatoprotectants and diuretics,and 105 (43.93％) patients received anticoagulant drugs.The mortality rate was 8.37％ (20/239).The percentage of patients with no improvement or deterioration was 17.57％ (42/239).Increased total bilirubin and lactic dehydrogenase levels were related with poor prognosis (the relative risk was 1.012 and 1.009,respectively;both P＜ 0.05).Conclusions Gynura segetum is a major cause of hospitalized patients with HSOS in China.Ascites is the major clinical manifestation.The patchy enhancement,heterogeneous hypoattenuation of CT or inhomogeneous signal of MRI are the main CT/MRI signs of HSOS.There are no reliable and effective treatments for Gynura segetum-related HSOS and the mortality is relatively low.

Hepatic Veno-Occlusive Disease Induced by Gymura Segetum: Report of Two Cases

Clinical Analysis of Hepatic Veno-Occlusive Disease Induced by Sedum Aizoon

Clinical Analysis of 50 Cases of Hepatic Veno-Occlusive Disease

Hepatic Sinusoidal Obstruction Syndrome Caused by the Ingestion of Gynura Segetum in a Patient with Alcoholic Cirrhosis: a Case Report.

Clinical and pathologic study on hepatic veno-occlusive disease

Clinical analysis on gynura segetum induced hepatic veno-occlusive disease

Clinical Characteristics and Outcomes of Patients with Hepatic Veno-Occlusive Disease Induced by Gynura Segetum: A Retrospective Study

Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.

Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report

Treatment for Gynura Segetum Caused Hepatic Vein Occlusive Disease: a Single-Center Retrospective Study

Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.

Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome

Hepatic Veno-Occlusive Disease May Be a Rare Characteristic of Hepatic Involvement in Systemic Amyloidosis: Case Report and Literature Review

Gynura Segetum-Related Hepatic Sinusoidal Obstruction Syndrome: a National Multicenter Clinical Study

Definitive Diagnosis of Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids.

Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by <i>Gynura japonica</i> Containing Pyrrolizidine Alkaloids

Tusanqi and Hepatic Sinusoidal Obstruction Syndrome

[Clinical Characteristics of Hepatic Sinusoidal Obstruction Syndrome: Analysis of 8 Cases].

Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Gynura japonica Containing Pyrrolizidine Alkaloids

Expression of MMP-9 in Hepatic Sinusoidal Obstruction Syndrome Induced by Gynura Segetum

Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China